相关实验视频
Updated: Jul 6, 2025

12:59
Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
Published on: September 26, 2013
34.5K
由IL-17A驱动的牛皮严重依赖IL-36信号传递
Berenice Fischer1, Tanja Kübelbeck1, Antonia Kolb1
1Department of Dermatology, University Medical Center of the Johannes Gutenberg-University of Mainz, Mainz, Germany.
Frontiers in immunology
|January 1, 2024
概括
用抗体准IL-36受体 (IL36R) 途径在牛皮模型中有效抑制皮肤炎症. 这种方法可能为IL-17A驱动的牛皮和相关疾病提供一种新的治疗方法.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 自身免疫性疾病是一种自身免疫性疾病.
- 分子生物学分子生物学
背景情况:
- 斑块性牛皮是一种常见的炎症性皮肤疾病,其特征是角质细胞的过度增殖和免疫细胞的透.
- 高水平的IL-36家族细胞因子与牛皮皮肤病变的发病有关.
- 抗IL36受体 (IL36R) 抗体已被批准用于一般性性牛皮 (GPP),但它们在斑块牛皮的疗效尚未完全理解.
研究的目的:
- 为了研究IL36R抑制在斑块性牛皮的治疗潜力.
- 评估抗IL36R抗体对牛皮样皮肤炎症和全身炎症的影响.
主要方法:
- 在伊米基莫德诱导的牛皮样皮肤炎症模型中,抗体介导IL36R的抑制.
- 在依赖IL-17A过度表达的模型中评估疾病发展.
- 评估对皮肤和全身炎症的影响.
主要成果:
- 抗体介导的IL36R抑制抑制了因伊米基莫德诱导的牛皮样皮肤炎症.
- 在依赖IL-17A的模型中,IL36R阻断抑制了疾病的发展.
- 用抗IL36R抗体治疗减少了与牛皮相关的皮肤和全身炎症.
结论:
- 抑制IL-36信号通路是有效的抑制牛皮状皮肤炎症.
- 阻断IL36R可能会影响状细胞和免疫细胞的激活,导致广泛的抗炎作用.
- 向IL-36通路为IL-17A驱动的牛皮和相关并发症提供了一个有希望的替代治疗策略.
相关概念视频
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K

